Target intelligence / Profile preview

Docking protein 1, 62kDa (downstream of tyrosine kinase 1) pseudogene (DOK1 pseudogene)

Target
DOK1 pseudogene
Molecular classification
Other, Pseudogene
01

Overview

ENSG00000228286 encodes the Docking protein 1, 62kDa (downstream of tyrosine kinase 1) pseudogene in Homo sapiens[1][3]. It is annotated as a pseudogene, meaning it is derived from the protein-coding gene DOK1 but has accumulated mutations that prevent it from producing a functional protein[1][3][4]. Pseudogenes typically lack protein-coding capability and, therefore, are not considered therapeutic targets and have no known roles in drug interactions, diagnostics, or disease management[4]. There is no current evidence suggesting that this specific pseudogene has regulatory or protein-coding function, nor is it known to be involved in any specific biological process, disease, or considered for biomarker use[1][3][4]. Thus, it is not a valid target for therapeutic intervention, and its listing as a target is considered incorrect[1][3][4].

Other names
AP000593.2DOK1 pseudogene
02

Biological functions

Other (no confirmed biological function; typical of pseudogenes)

Beyond the preview

Go deeper on Docking protein 1, 62kDa (downstream of tyrosine kinase 1) pseudogene (DOK1 pseudogene).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Docking protein 1, 62kDa (downstream of tyrosine kinase 1) pseudogene (DOK1 pseudogene).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call